Actively Recruiting
3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers
Led by New York University · Updated on 2026-02-27
75
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical study aims to evaluate the clinical performance of 3M™ Filtek™ Supreme Flowable Composite in class IV and veneer indication. Follow-ups of 7 days, 6, 12, and 24 months will be conducted following an Fédération Dentaire Internationale (FDI) modified score (2023). A minimum of 50 Class IV and 25 veneers will be included in the evaluation. Research data and pictures will be provided for each patient pre-op and at 7 days (baseline, 6 months, 12 months and 24 months. Evaluation will be conducted by two calibrated evaluators different from the operator according to FDI clinical criteria.
CONDITIONS
Official Title
3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years old
- Willing and able to provide informed consent to participate
- Available for all required post-operative follow-up visits
- In good general health
- Good oral hygiene with a plaque score less than 20%
- Have at least 6 anterior maxillary teeth
- Central and lateral incisors with Class IV or veneer indications; veneers must be performed on paired contralateral teeth
You will not qualify if you...
- Single tooth veneers
- Canine teeth
- Periodontal disease
- Pulpal diseases
- Occlusal dysfunctions such as end-to-end bite
- Lack of occlusal stability
- Missing posterior teeth affecting bite distribution
- Tooth mobility greater than grade 2 on study, adjacent, or opposing teeth
- Systemic or local disorders contraindicating dental procedures
- Rampant, uncontrolled tooth decay
- Heavy tobacco use (1 pack or more per day) or chewing tobacco
- Dry mouth (xerostomia)
- Severe teeth grinding or clenching or need for TMJ therapy
- Known allergy or sensitivity to study materials
- Chronic use of anti-inflammatory, analgesic, or mind-altering drugs affecting pain perception
- Tooth surface loss (attrition, erosion, abrasion, or abfraction) impacting pain perception
- Participation in other dental material clinical trials
- Investigator's judgment of unsuitability
- Pregnant at enrollment or procedure visit (confirmed by urine test)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU College Of Dentistry
New York, New York, United States, 10010
Actively Recruiting
Research Team
M
Mariana Bucovsky
CONTACT
L
Leticia Arbex
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here